Innate Pharma SA (the “Company” - Euronext Paris: FR0010331421 – IPH), announces that it will host an event for analysts and investors in London to discuss the Company’s corporate strategy and ongoing programs, science and R&D strategy.
Hervé Brailly, CEO and Co-Founder, Nicolai Wagtmann, CSO and Pierre Dodion, CMO, will host a presentation and lunch at 12.00 BST on Wednesday 13 July 2016 at the offices of Consilium Strategic Communications, 41 Lothbury, London, EC2R 7HG.
If you would like to attend the event, please contact Consilium Strategic Communications at InnatePharma@consilium-comms.com or +44 (0)20 3709 5700. For those who are unable to attend in person, a live webcast and replay will be accessible at the following link:
Replay of the call is available here
A replay of the webcast will be made available on the “Innate Live” section of the website shortly after the event.
| Presentation analyst and investor event - London | 5.7 MB |
| PR in English | 71.42 KB |
| CP en français | 32.32 KB |